A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8150 (MK-8150-002)

Clinical trial NCT01656408 · COMPLETED

Trial details

NCT number: NCT01656408
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypertension Isolated Systolic Hypertension

Start date: 2012-08-01
Primary completion: 2013-05-03
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.